Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
41
PLAB Quote, Financials, Valuation and Earnings
Last price:
$19.63
Seasonality move
:
-4.66%
Day range:
$19.09 - $19.81
52-week range:
$16.46 - $31.60
Dividend yield:
0%
P/E ratio:
10.22x
P/S ratio:
1.42x
P/B ratio:
1.07x
Volume:
544.9K
Avg. volume:
578.3K
1-year change:
-26.51%
Market cap:
$1.2B
Revenue:
$866.9M
EPS (TTM):
$1.92
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $609.7M | $663.8M | $824.5M | $892.1M | $866.9M | |
| Revenue Growth (YoY) | 10.72% | 8.87% | 24.22% | 8.19% | -2.82% | |
| Cost of Revenues | $475M | $496.7M | $530.3M | $555.9M | $551M | |
| Gross Profit | $134.7M | $167M | $294.2M | $336.2M | $315.9M | |
| Gross Profit Margin | 22.09% | 25.17% | 35.68% | 37.68% | 36.44% | |
| R&D Expenses | $17.1M | $18.5M | $18.3M | $13.7M | $16.6M | |
| Selling, General & Admin | $53.6M | $57.5M | $64M | $69.5M | $77.8M | |
| Other Inc / (Exp) | -$501K | $8M | $27.3M | $2.5M | $2.2M | |
| Operating Expenses | $70.7M | $72.5M | $82.3M | $83.1M | $94.4M | |
| Operating Income | $63.9M | $94.6M | $211.9M | $253.1M | $221.5M | |
| Net Interest Expenses | $1.8M | $520K | $177K | -- | -- | |
| EBT. Incl. Unusual Items | $61.6M | $102M | $239M | $269.9M | $247.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $21.3M | $23.2M | $59.8M | $70.3M | $63.6M | |
| Net Income to Company | $40.3M | $78.8M | $179.2M | $199.6M | $183.8M | |
| Minority Interest in Earnings | -$6.5M | -$23.4M | -$60.5M | -$74.1M | -$53.2M | |
| Net Income to Common Excl Extra Items | $33.8M | $55.4M | $118.8M | $125.5M | $130.7M | |
| Basic EPS (Cont. Ops) | $0.52 | $0.90 | $1.96 | $2.05 | $2.12 | |
| Diluted EPS (Cont. Ops) | $0.52 | $0.89 | $1.94 | $2.03 | $2.09 | |
| Weighted Average Basic Share | $64.9M | $61.4M | $60.6M | $61.1M | $61.7M | |
| Weighted Average Diluted Share | $65.5M | $62M | $61.2M | $61.8M | $62.4M | |
| EBITDA | $157.8M | $194.1M | $321.2M | $351.2M | $330.6M | |
| EBIT | $64M | $103.7M | $240.9M | $270.4M | $247.7M | |
| Revenue (Reported) | $609.7M | $663.8M | $824.5M | $892.1M | $866.9M | |
| Operating Income (Reported) | $63.9M | $94.6M | $211.9M | $253.1M | $221.5M | |
| Operating Income (Adjusted) | $64M | $103.7M | $240.9M | $270.4M | $247.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $159.8M | $204.5M | $229.3M | $217M | $211M | |
| Revenue Growth (YoY) | 11.9% | 28.01% | 12.13% | -5.37% | -2.77% | |
| Cost of Revenues | $120.5M | $134.3M | $140.9M | $137.7M | $133.1M | |
| Gross Profit | $39.2M | $70.2M | $88.4M | $79.3M | $77.9M | |
| Gross Profit Margin | 24.57% | 34.34% | 38.55% | 36.52% | 36.92% | |
| R&D Expenses | $4.4M | $4.2M | $3.5M | $4.3M | $4.1M | |
| Selling, General & Admin | $14.1M | $16.6M | $17.9M | $19M | $18.1M | |
| Other Inc / (Exp) | -$2.1M | $7.8M | $10.7M | $14.8M | -$31.1M | |
| Operating Expenses | $18.4M | $20.8M | $21.4M | $23.2M | $22.2M | |
| Operating Income | $20.8M | $49.4M | $67M | $56.1M | $55.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $20M | $57.4M | $80.6M | $76.6M | $29.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $14.4M | $21.3M | $20.2M | $5.7M | |
| Net Income to Company | $16.3M | $43M | $59.3M | $56.4M | $24.2M | |
| Minority Interest in Earnings | -$5.8M | -$15.6M | -$19.3M | -$20.1M | -$15.4M | |
| Net Income to Common Excl Extra Items | $10.5M | $27.4M | $39.9M | $36.3M | $8.9M | |
| Basic EPS (Cont. Ops) | $0.17 | $0.45 | $0.65 | $0.59 | $0.15 | |
| Diluted EPS (Cont. Ops) | $0.17 | $0.45 | $0.65 | $0.58 | $0.15 | |
| Weighted Average Basic Share | $62.1M | $60.6M | $61.1M | $61.8M | $60.8M | |
| Weighted Average Diluted Share | $62.6M | $61.1M | $61.5M | $62.4M | $61M | |
| EBITDA | $44.2M | $70M | $100.7M | $97.5M | $49.5M | |
| EBIT | $20.8M | $49.4M | $80.8M | $76.7M | $29.9M | |
| Revenue (Reported) | $159.8M | $204.5M | $229.3M | $217M | $211M | |
| Operating Income (Reported) | $20.8M | $49.4M | $67M | $56.1M | $55.7M | |
| Operating Income (Adjusted) | $20.8M | $49.4M | $80.8M | $76.7M | $29.9M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $619M | $746.3M | $870.6M | $885M | $856.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $479.6M | $518.9M | $542M | $554.8M | $545.9M | |
| Gross Profit | $139.4M | $227.3M | $328.6M | $330.2M | $310.9M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $17.7M | $19.6M | $15M | $14.6M | $17.2M | |
| Selling, General & Admin | $54.2M | $61.7M | $66.3M | $72.1M | $77.6M | |
| Other Inc / (Exp) | -$4.5M | $21.8M | $8M | $14.6M | -$16.4M | |
| Operating Expenses | $71.9M | $77.8M | $81.3M | $86.6M | $95M | |
| Operating Income | $67.5M | $149.6M | $247.3M | $243.6M | $215.9M | |
| Net Interest Expenses | $686K | $1.5M | -- | -- | -- | |
| EBT. Incl. Unusual Items | $62.3M | $169.9M | $260.9M | $278.1M | $224.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $15.1M | $42.1M | $68.1M | $71.3M | $53.3M | |
| Net Income to Company | $47.3M | $127.7M | $192.7M | $206.9M | $170.9M | |
| Minority Interest in Earnings | -$11.5M | -$40.4M | -$70.5M | -$72.9M | -$50.9M | |
| Net Income to Common Excl Extra Items | $35.8M | $87.4M | $122.2M | $134M | $120M | |
| Basic EPS (Cont. Ops) | $0.57 | $1.44 | $2.00 | $2.19 | $1.95 | |
| Diluted EPS (Cont. Ops) | $0.57 | $1.44 | $1.99 | $2.16 | $1.92 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $158.3M | $249.5M | $340M | $361.8M | $306.1M | |
| EBIT | $65.3M | $164.8M | $262M | $278.6M | $224.4M | |
| Revenue (Reported) | $619M | $746.3M | $870.6M | $885M | $856.7M | |
| Operating Income (Reported) | $67.5M | $149.6M | $247.3M | $243.6M | $215.9M | |
| Operating Income (Adjusted) | $65.3M | $164.8M | $262M | $278.6M | $224.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $311.8M | $394.3M | $440.4M | $433.3M | $423.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $242.1M | $264.3M | $275.9M | $274.8M | $269.7M | |
| Gross Profit | $69.8M | $130.1M | $164.5M | $158.5M | $153.4M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $9.1M | $10.1M | $6.8M | $7.7M | $8.3M | |
| Selling, General & Admin | $28.1M | $32.3M | $34.7M | $37.3M | $37.2M | |
| Other Inc / (Exp) | -$673K | $13.1M | -$6.2M | $5.9M | -$12.7M | |
| Operating Expenses | $37.2M | $42.5M | $41.5M | $45M | $45.5M | |
| Operating Income | $32.6M | $87.6M | $123M | $113.5M | $107.9M | |
| Net Interest Expenses | $702K | $561K | -- | -- | -- | |
| EBT. Incl. Unusual Items | $32.5M | $100.3M | $122.1M | $130.3M | $107.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7M | $25.6M | $33.9M | $34.9M | $24.6M | |
| Net Income to Company | $25.8M | $74.8M | $88.2M | $95.5M | $82.5M | |
| Minority Interest in Earnings | -$7.3M | -$24.3M | -$34.3M | -$33M | -$30.8M | |
| Net Income to Common Excl Extra Items | $18.6M | $50.5M | $53.9M | $62.4M | $51.7M | |
| Basic EPS (Cont. Ops) | $0.30 | $0.83 | $0.88 | $1.02 | $0.84 | |
| Diluted EPS (Cont. Ops) | $0.30 | $0.83 | $0.88 | $1.00 | $0.83 | |
| Weighted Average Basic Share | $124.5M | $120.8M | $122M | $123.2M | $122.9M | |
| Weighted Average Diluted Share | $125.6M | $122.1M | $123M | $124.7M | $123.6M | |
| EBITDA | $81.2M | $134.6M | $161.4M | $172M | $147.5M | |
| EBIT | $34.1M | $93.2M | $122.3M | $130.5M | $107.1M | |
| Revenue (Reported) | $311.8M | $394.3M | $440.4M | $433.3M | $423.1M | |
| Operating Income (Reported) | $32.6M | $87.6M | $123M | $113.5M | $107.9M | |
| Operating Income (Adjusted) | $34.1M | $93.2M | $122.3M | $130.5M | $107.1M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $278.7M | $276.7M | $319.7M | $499.3M | $598.5M | |
| Short Term Investments | -- | -- | $38.8M | $12.9M | $42.2M | |
| Accounts Receivable, Net | $134.5M | $174.4M | $198.1M | $194.9M | $200.8M | |
| Inventory | $57.3M | $55.2M | $50.8M | $50M | $56.5M | |
| Prepaid Expenses | $122K | $9.5M | $18M | $12.5M | $7.6M | |
| Other Current Assets | $608K | $629K | $814K | $2.5M | $6.2M | |
| Total Current Assets | $500.1M | $550.6M | $644.7M | $785.5M | $931.1M | |
| Property Plant And Equipment | $631.5M | $696.6M | $643.9M | $709.2M | $745.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $3.4M | -- | -- | -- | -- | |
| Other Long-Term Assets | $31.1M | $22.7M | $7.5M | $10.2M | $12.7M | |
| Total Assets | $1.2B | $1.3B | $1.3B | $1.5B | $1.7B | |
| Accounts Payable | $75.4M | $81.5M | $79.6M | $84M | $78.7M | |
| Accrued Expenses | $13.9M | $14.6M | $10.4M | $17.9M | $14.6M | |
| Current Portion Of Long-Term Debt | $13.7M | $15M | $3.5M | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.2M | $9.6M | $7.9M | $8.5M | $19.9M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $142.9M | $176.1M | $193.8M | $185.2M | $183.8M | |
| Long-Term Debt | $55M | $58.4M | $7.7M | -- | $25K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $225.9M | $293.6M | $253.7M | $250.6M | $231.3M | |
| Common Stock | $631K | $600K | $608K | $613K | $619K | |
| Other Common Equity Adj | -- | -- | -- | -$88.7M | -$86.3M | |
| Common Equity | $805M | $823.7M | $831.5M | $975M | $1.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $157.3M | $176.9M | $230.6M | $300.6M | $359.9M | |
| Total Equity | $962.3M | $1B | $1.1B | $1.3B | $1.5B | |
| Total Liabilities and Equity | $1.2B | $1.3B | $1.3B | $1.5B | $1.7B | |
| Cash and Short Terms | $278.7M | $276.7M | $358.5M | $512.2M | $640.7M | |
| Total Debt | $68.7M | $73.3M | $11.3M | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $256M | $329.3M | $367.5M | $493.9M | $530.7M | |
| Short Term Investments | -- | -- | $45.4M | $66M | $27.7M | |
| Accounts Receivable, Net | $143.9M | $190.3M | $214.5M | $175M | $165.4M | |
| Inventory | $56.4M | $57.9M | $54.9M | $54.3M | $61.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $39.3M | $52.9M | $37.8M | $32.5M | $40.2M | |
| Total Current Assets | $495.6M | $630.3M | $720.1M | $844.1M | $855.8M | |
| Property Plant And Equipment | $717.4M | $659.9M | $699.9M | $729.5M | $807.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $29M | $17.9M | $11.7M | $10M | $14.9M | |
| Total Assets | $1.3B | $1.3B | $1.5B | $1.6B | $1.7B | |
| Accounts Payable | $83.3M | $78.3M | $92.7M | $94.7M | $89.5M | |
| Accrued Expenses | $50.3M | $95.7M | $85.5M | $81.5M | $77.3M | |
| Current Portion Of Long-Term Debt | $18.1M | $5.5M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $7.5M | $6.9M | $7M | $19.3M | $11K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $159.3M | $186.5M | $185.2M | $195.6M | $166.8M | |
| Long-Term Debt | $54.1M | $42.3M | -- | -- | $19K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $275.2M | $281.7M | $246.3M | $235.4M | $206.3M | |
| Common Stock | $636K | $606K | $612K | $618K | $587K | |
| Other Common Equity Adj | -- | -- | -- | -$95.9M | -$87.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $169.4M | $215.8M | $276.6M | $333.2M | $395.8M | |
| Total Equity | $990.8M | $1.1B | $1.2B | $1.4B | $1.5B | |
| Total Liabilities and Equity | $1.3B | $1.3B | $1.5B | $1.6B | $1.7B | |
| Cash and Short Terms | $256M | $329.3M | $412.9M | $559.9M | $558.4M | |
| Total Debt | $72.3M | $47.8M | -- | -- | -- | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $40.3M | $78.8M | $179.2M | $199.6M | $183.8M | |
| Depreciation & Amoritzation | $93.8M | $90.4M | $80.3M | $80.8M | $82.8M | |
| Stock-Based Compensation | $4.9M | $5.3M | $6.3M | $8M | $13.9M | |
| Change in Accounts Receivable | $7M | -$36.6M | -$51.2M | $4M | -$2.5M | |
| Change in Inventories | -$6.9M | $3M | -$2M | $1.2M | -$6.2M | |
| Cash From Operations | $143M | $150.8M | $275.2M | $302.2M | $261.4M | |
| Capital Expenditures | $71M | $109.3M | $112.5M | $131.4M | $131M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$65.7M | -$103.5M | -$147.8M | -$101.5M | -$156.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $20.3M | $20.9M | -- | -- | -- | |
| Long-Term Debt Repaid | -$7.4M | -$20.4M | -$65.4M | -$18.4M | -$6.6M | |
| Repurchase of Common Stock | -$34.4M | -$48.2M | -$2.5M | -- | -- | |
| Other Financing Activities | $5.4M | -$9.6M | $25M | -- | $1.9M | |
| Cash From Financing | -$16M | -$53.9M | -$38.7M | -$18.5M | -$7.7M | |
| Beginning Cash (CF) | $209.3M | $281.6M | $279.7M | $322.4M | $501.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $61.3M | -$6.6M | $88.7M | $182.1M | $97.2M | |
| Ending Cash (CF) | $281.6M | $276.7M | $319.7M | $499.3M | $598.5M | |
| Levered Free Cash Flow | $72.1M | $41.5M | $162.6M | $170.8M | $130.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $16.3M | $43M | $59.3M | $56.4M | $24.2M | |
| Depreciation & Amoritzation | $23.4M | $20.6M | $20M | $20.8M | $19.6M | |
| Stock-Based Compensation | $1.4M | $1.6M | $2M | $3.9M | $3.4M | |
| Change in Accounts Receivable | -$3.6M | -$28.4M | $1.6M | $491K | -$3.6M | |
| Change in Inventories | $171K | $1.9M | -$3.6M | -$4.8M | -$2.2M | |
| Cash From Operations | $31.9M | $44.2M | $82M | $76.5M | $31.5M | |
| Capital Expenditures | $56M | $15.6M | $26.6M | $20M | $60.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$50.7M | -$14.4M | -$32.1M | -$72.5M | -$87.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6.2M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$840K | -$12.4M | -$5.5M | -$1.7M | -$2.6M | |
| Repurchase of Common Stock | -$10M | -- | -- | -- | -$72.1M | |
| Other Financing Activities | -- | $14.4M | $58K | $119K | $150K | |
| Cash From Financing | -$4.3M | -$1.8M | -$5.5M | -$1.9M | -$74.6M | |
| Beginning Cash (CF) | $281.5M | $317.2M | $334.8M | $508.5M | $642.2M | |
| Foreign Exchange Rate Adjustment | $491K | -$12.9M | -$11.9M | -$16.9M | $19.5M | |
| Additions / Reductions | -$23.1M | $27.9M | $44.4M | $2.1M | -$130.8M | |
| Ending Cash (CF) | $259M | $332.3M | $367.5M | $493.9M | $530.7M | |
| Levered Free Cash Flow | -$24.1M | $28.5M | $55.4M | $56.5M | -$29.1M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $47.3M | $127.7M | $192.7M | $206.9M | $170.9M | |
| Depreciation & Amoritzation | $93M | $84.7M | $78M | $83.2M | $81.7M | |
| Stock-Based Compensation | $5.1M | $5.7M | $7.1M | $10.7M | $14.1M | |
| Change in Accounts Receivable | $1.3M | -$56.1M | -$32.1M | $7.6M | $4.2M | |
| Change in Inventories | $4.3M | -$4.4M | $1.1M | -$1.3M | -$6.4M | |
| Cash From Operations | $139.9M | $195.8M | $281.6M | $310.5M | $253.4M | |
| Capital Expenditures | $114.4M | $70.6M | $135.5M | $137M | $163.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$108.6M | -$69.2M | -$176.4M | -$154M | -$122.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.6M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$15.6M | -$39.3M | -$52.6M | -$6.6M | -$21.7M | |
| Repurchase of Common Stock | -$40.8M | -$27.5M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$3.7M | $325K | $528K | |
| Cash From Financing | -$29.3M | -$37.4M | -$51.8M | -$8M | -$98.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.1M | $89.2M | $53.4M | $148.5M | $32.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $25.6M | $125.3M | $146.1M | $173.5M | $89.9M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.8M | $74.8M | $88.2M | $95.5M | $82.5M | |
| Depreciation & Amoritzation | $47.1M | $41.4M | $39.1M | $41.5M | $40.4M | |
| Stock-Based Compensation | $2.7M | $3M | $3.8M | $6.5M | $6.7M | |
| Change in Accounts Receivable | -$5.7M | -$25.1M | -$6M | -$2.4M | $4.3M | |
| Change in Inventories | $2.3M | -$5.1M | -$1.9M | -$4.4M | -$4.7M | |
| Cash From Operations | $58.2M | $103.3M | $109.7M | $118M | $109.9M | |
| Capital Expenditures | $73.5M | $34.8M | $57.7M | $63.3M | $95.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$67.9M | -$33.6M | -$62.3M | -$114.7M | -$80.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $12.4M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.6M | -$27.6M | -$14.7M | -$2.8M | -$18M | |
| Repurchase of Common Stock | -$23.3M | -$2.5M | -- | -- | -$76.7M | |
| Other Financing Activities | -- | $29.4M | $730K | $1.1M | $1.6M | |
| Cash From Financing | -$18.6M | -$2.2M | -$15.2M | -$4.7M | -$95.1M | |
| Beginning Cash (CF) | $563.1M | $596.9M | $657.2M | $1B | $1.2B | |
| Foreign Exchange Rate Adjustment | $5.7M | -$14.9M | $15.6M | -$3.8M | -$1.7M | |
| Additions / Reductions | -$28.3M | $67.5M | $32.2M | -$1.4M | -$66M | |
| Ending Cash (CF) | $540.5M | $649.5M | $702.3M | $1B | $1.2B | |
| Levered Free Cash Flow | -$15.3M | $68.5M | $51.9M | $54.7M | $14.2M | |
Get PLAB Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PLAB
Sector
P/E ratio
10.22x
23.75x
PEG ratio
1.34x
0.00x
P/B ratio
1.07x
2.35x
Price / LTM sales
1.42x
1.66x
Growth Metrics
PLAB
Sector
Revenue growth
-2.77%
3.91%
Earnings growth
-74.14%
11.1%
Revenue (5-year growth)
9.5%
6.27%
Earnings forecast
$0.48
$0.12
Profitability
PLAB
Sector
Profitability FY 2024
$315.9M
$76.5M
Return on invested capital
8.27%
0.05%
Return on assets
7.17%
-0.48%
Return on equity
8.27%
0.73%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Aug
29
Estimated Next Earnings Date
Aug
27
Balance Sheet
PLAB
Sector
Total cash
$558.4M
$48.7M
Short term investments
$42.2M
$19.4M
Total assets
$1.7B
$223.8M
Long term debt
--
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
